{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:48:07Z","timestamp":1782143287593,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.neurol.2017.06.030","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T05:41:14Z","timestamp":1520487674000},"page":"150-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Association of vitamin D status with multiple sclerosis in a case-control study from Morocco"],"prefix":"10.1016","volume":"174","author":[{"given":"A.","family":"Skalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.H.","family":"Ait Ben Haddou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"El Jaoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Razine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"Mpandzou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tibar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"El Fahime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bouslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Benomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hajjout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Yahyaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bouhouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2017.06.030_bib0260","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1878-5085-4-4","article-title":"Can we prevent or treat multiple sclerosis by individualised vitamin D supply?","volume":"4","author":"D\u00f6rr","year":"2013","journal-title":"EPMA J"},{"issue":"1","key":"10.1016\/j.neurol.2017.06.030_bib0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1756285608100325","article-title":"Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment","volume":"2","author":"Haussleiter","year":"2009","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.neurol.2017.06.030_bib0270","first-page":"124578","article-title":"Spatial analysis of global prevalence of multiple sclerosis suggests need for an updated prevalence scale","volume":"2014","author":"Wade","year":"2014","journal-title":"Mult Scler Int"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2017.06.030_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2008.12.001","article-title":"Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review","volume":"278","author":"Benamer","year":"2009","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.neurol.2017.06.030_bib0280","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1586\/1744666X.3.5.739","article-title":"Risk factors in the development of multiple sclerosis","volume":"3","author":"Munger","year":"2007","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.neurol.2017.06.030_bib0285","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1756285612473513","article-title":"Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis","volume":"6","author":"Pierrot-Deseilligny","year":"2013","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"10.1016\/j.neurol.2017.06.030_bib0290","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1371\/journal.pone.0004565","article-title":"The causal cascade to multiple sclerosis: a model for MS pathogenesis","volume":"4","author":"Goodin","year":"2009","journal-title":"PLoS One"},{"issue":"7410","key":"10.1016\/j.neurol.2017.06.030_bib0295","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/bmj.327.7410.316","article-title":"Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study","volume":"327","author":"Van der Mei","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.neurol.2017.06.030_bib0300","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00415-006-0395-5","article-title":"Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle","volume":"254","author":"Kampman","year":"2007","journal-title":"J Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2017.06.030_bib0305","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/01.wnl.0000323928.57408.93","article-title":"Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis","volume":"71","author":"Dwyer","year":"2008","journal-title":"Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2017.06.030_bib0310","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S0317167100007587","article-title":"The relation of ultraviolet radiation and multiple sclerosis in Newfoundland","volume":"35","author":"Sloka","year":"2008","journal-title":"Can. J Neurol Sci"},{"key":"10.1016\/j.neurol.2017.06.030_bib0315","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.3390\/ijerph110606417","article-title":"Environmental factors and multiple sclerosis severity: a descriptive study","volume":"11","author":"Mandia","year":"2014","journal-title":"Int J Environ Res Publ Health"},{"issue":"5","key":"10.1016\/j.neurol.2017.06.030_bib0320","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.35.5.672","article-title":"Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS","volume":"35","author":"Kurtzke","year":"1985","journal-title":"Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2017.06.030_bib0325","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000054783","article-title":"Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation","volume":"20","author":"Van der Mei","year":"2001","journal-title":"Neuroepidemiology"},{"issue":"7","key":"10.1016\/j.neurol.2017.06.030_bib0330","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1468-1331.2006.01342.x","article-title":"The epidemiology of multiple sclerosis in Europe","volume":"13","author":"Pugliatti","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2017.06.030_bib0335","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s00415-009-5139-x","article-title":"Clinical implications of a possible role of vitamin D in multiple sclerosis","volume":"256","author":"Pierrot-Deseilligny","year":"2009","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2017.06.030_bib0340","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis","volume":"62","author":"Munger","year":"2004","journal-title":"Neurol"},{"key":"10.1016\/j.neurol.2017.06.030_bib0345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0404.1995.tb05858.x","article-title":"Multiple sclerosis in Scandinavia and Finland","volume":"161","author":"Koch-Henderson","year":"1995","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.neurol.2017.06.030_bib0350","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/PL00007793","article-title":"Multiple sclerosis in North Norway, and first appearance in an indigenous population","volume":"247","author":"Gr\u00f8nlie","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2017.06.030_bib0355","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awp033","article-title":"Immunomodulatory effects of vitamin D in multiple sclerosis","volume":"132","author":"Correale","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurol.2017.06.030_bib0360","first-page":"1","article-title":"Vitamin D and multiple sclerosis","volume":"13","author":"Amini Harandi","year":"2014","journal-title":"Iran J Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2017.06.030_bib0365","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/jnr.20826","article-title":"1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12\/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis","volume":"83","author":"Muthian","year":"2006","journal-title":"J Neurosci Res"},{"issue":"9","key":"10.1016\/j.neurol.2017.06.030_bib0370","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.4049\/jimmunol.177.9.6030","article-title":"IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of Experimental Autoimmune Encephalomyelitis","volume":"177","author":"Spach","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.neurol.2017.06.030_bib0375","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2017.06.030_bib0380","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2017.06.030_bib0385","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.neurol.2017.06.030_bib0390","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0404.1998.tb01738.x","article-title":"Multiple sclerosis in North African migrants to France","volume":"98","author":"Kurtzke","year":"1998","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.neurol.2017.06.030_bib0395","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1212\/01.wnl.0000250347.51674.d7","article-title":"More severe disability of North Africans vs. Europeans with multiple sclerosis in France","volume":"68","author":"Debouverie","year":"2007","journal-title":"Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2017.06.030_bib0400","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.msard.2014.09.020","article-title":"Is multiple sclerosis more disabling in North African patients?","volume":"3","author":"Slassi","year":"2014","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"10.1016\/j.neurol.2017.06.030_bib0405","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","article-title":"High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis","volume":"44","author":"Nieves","year":"1994","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurol.2017.06.030_bib0410","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/1352458509102844","article-title":"Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis","volume":"15","author":"Hiremath","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2017.06.030_bib0415","first-page":"w13192","article-title":"Vitamin D levels in Swiss multiple sclerosis patients","volume":"141","author":"Yildiz","year":"2011","journal-title":"Swiss Med Wkly"},{"issue":"5","key":"10.1016\/j.neurol.2017.06.030_bib0420","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00415-006-0315-8","article-title":"Vitamin D levels in people with multiple sclerosis and community controls in Tasmania","volume":"254","author":"Van der Mei","year":"2007","journal-title":"Australia J Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2017.06.030_bib0425","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jnnp.2006.105320","article-title":"A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis","volume":"79","author":"Soilu-H\u00e4nninen","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2017.06.030_bib0430","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1212\/WNL.0b013e31821cccf5","article-title":"Vitamin D in African Americans with multiple sclerosis","volume":"76","author":"Gelfand","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2017.06.030_bib0435","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neurol.2010.10.002","article-title":"[Vitamin D and multiple sclerosis. A prospective survey of patients of Poitou-Charentes area]","volume":"167","author":"Neau","year":"2011","journal-title":"Rev Neurol (Paris)"},{"issue":"9","key":"10.1016\/j.neurol.2017.06.030_bib0440","doi-asserted-by":"crossref","first-page":"e45703","DOI":"10.1371\/journal.pone.0045703","article-title":"Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study","volume":"7","author":"Moen","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neurol.2017.06.030_bib0445","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jnnp.2010.220988","article-title":"Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype","volume":"82","author":"Lonergan","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.neurol.2017.06.030_bib0450","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1191\/1352458505ms1157oa","article-title":"25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis","volume":"11","author":"Soilu-H\u00e4nninen","year":"2005","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.neurol.2017.06.030_bib0455","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/1352458506072666","article-title":"Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers","volume":"13","author":"Barnes","year":"2007","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.neurol.2017.06.030_bib0460","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1468-1331.2011.03650.x","article-title":"Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15","volume":"19","author":"B\u00e4\u00e4rnhielm","year":"2012","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2017.06.030_bib0465","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00774-005-0604-9","article-title":"Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity","volume":"23","author":"Ozgocmen","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.neurol.2017.06.030_bib0470","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.4049\/jimmunol.1000588","article-title":"Sclerosis patients and healthy subjects D3 immunomodulatory effects in multiple gender differences in 1,25 dihydroxyvitamin","volume":"185","author":"Correale","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.neurol.2017.06.030_bib0475","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clim.2015.03.011","article-title":"Risk factors for multiple sclerosis and associations with anti-EBV antibody titers","volume":"158","author":"Mouhieddine","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.neurol.2017.06.030_bib0480","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jneuroim.2015.11.017","article-title":"25-hydroxyvitamin D levels are associated with multiple sclerosis in Iran: a cross-sectional study","volume":"290","author":"Karampoor","year":"2016","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2017.06.030_bib0485","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jneuroim.2015.01.007","article-title":"Decreased serum vitamin D levels in Japanese patients with multiple sclerosis","volume":"279","author":"Niino","year":"2015","journal-title":"J Neuroimmunol"},{"issue":"23","key":"10.1016\/j.neurol.2017.06.030_bib0490","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin d levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2017.06.030_bib0495","first-page":"P280","article-title":"Vitamin D, race\/ethnicity and the risk of multiple sclerosis [abstract]","volume":"115449","author":"Langer-Gould","year":"2015","journal-title":"ECTRIMS Online Library"},{"issue":"1","key":"10.1016\/j.neurol.2017.06.030_bib0500","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1352458508095920","article-title":"Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women","volume":"15","author":"Kragt","year":"2009","journal-title":"Mult Scler"},{"issue":"9","key":"10.1016\/j.neurol.2017.06.030_bib0505","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/1352458508094399","article-title":"Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis","volume":"14","author":"Smolders","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2017.06.030_bib0510","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/ije\/dyt095","article-title":"Differences between blood donors and a population sample: implications for case\u2013control studies","volume":"42","author":"Golding","year":"2013","journal-title":"Int J Epidemiol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716303782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716303782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T16:25:13Z","timestamp":1660580713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378716303782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0035378716303782"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2017.06.030","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of vitamin D status with multiple sclerosis in a case-control study from Morocco","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2017.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}